Faster Paths to Treatment, is BMC’s substance use disorder urgent care program. It is a judgment-free home for people suffering with addiction. Staff members help individuals overcome their addiction by rapidly evaluating, motivating, and referring patients with substance use disorders to a network of care, including inpatient and outpatient detox, treatment, and aftercare services.

 

Contact Us

Conditions We Treat

Treatments & Services

  • Referral to addiction treatment
  • Assessment for medication for addiction treatment, including prescriptions for induction and stabilization on buprenorphine/naloxone (Suboxone), buprenorphine extended-release injection (Sublocade), naltrexone pills or injection (Vivitrol) for blocking cravings, and 72-hours of methadone dosing in certain circumstances
  • HIV prevention and treatment resources and medication
  • Opioid overdose education including naloxone (Narcan) rescue kits
  • Access to BMC case management, which can help with overcoming common barriers to health care, including transportation and acquiring a Massachusetts Identification Card
  • Access to a BMC primary care doctor
  • Access to community-based support services from the recovery specialists from Rapid ACCESS program

Our Team

Jessica L Taylor, MD

Assistant Professor of Medicine, Boston University School of Medicine

Special Interests

HIV, PrEP, Hepatitis C, Opioid Use Disorder, Medical Education
Placeholder image for doctor

Ricardo Cruz, MD

Instructor, Boston University School of Medicine, Boston MA

Special Interests

Primary Care , Latino Health

Placeholder image for doctor

Joanna L D'Afflitti, MD

Associate Medical Director, Assistant Professor of Medicine, Boston University School of Medicine, Boston MA

Special Interests

Internal Medicine

Theresa W Kim, MD

General Internal Medicine Physician

Special Interests

Internal Medicine, Addiction Medicine, Hepatitis C Treatment, HIV Infection

Miriam S Komaromy, MD

Professor of Medicine Boston University School of Medicine

Special Interests

Opioid Use Disorder, Alcohol Use Disorder, Tobacco Use Disorder, Substance Use Disorders

Miriam Komaromy headshot

Sandra S Looby-Gordon, MD

Assistant Professor of Medicine, Boston University School of Medicine, Boston MA

Special Interests

Internal Medicine, Addiction Medicine

OLYMPUS DIGITAL CAMERA

Alyssa F Peterkin, MD

Assistant Professor of Medicine, Associate Fellowship Director for the Grayken Addiction Medicine Fellowship

Special Interests

Substance Use Disorders, Inpatient care

Placeholder image for doctor

Jimmy Evans, RN, CARN
Addiction Nurse

Sandy Gonzalez
Program Manager

 

Additional Information

Research Overview

Partnering With State Health Departments to Address Injection-Related Infections During the Opioid Epidemic: Experience at a Safety Net Hospital - Burns RH, Pierre CM, Marathe JG, et al. . Open Forum Infect Dis. 2021;8(8):ofab208. Published 2021 Apr 27. 

Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings : Harm Reduction in Outpatient Addiction Treatment - Taylor JL, Johnson S, Cruz R, Gray JR, Schiff D, Bagley SM. [published online ahead of print, 2021 Jun 22]. J Gen Intern Med. 2021;1-10. doi:10.1007/s11606-021-06904-4

A collision of crises: Addressing an HIV outbreak among people who inject drugs in the midst of COVID-19. - Taylor JL, Ruiz-Mercado G, Sperring H, Bazzi AR. J Subst Abuse Treat. 2021;124:108280. doi:10.1016/j.jsat.2021.108280

Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report. - Harris M, Johnson S, Mackin S, Saitz R, Walley AY, Taylor JL. J Addict Med. 2020;14(4):e136-e138. doi:10.1097/ADM.0000000000000682

Stuck in the window with you: HIV exposure prophylaxis in the highest risk people who inject drugs Taylor JL, Walley AY, Bazzi AR. : . Subst Abus. 2019;40(4):441-443. doi:10.1080/08897077.2019.1675118

Residency and Fellowship Information

Addiction Medicine Fellowship

The mission of the Grayken Fellowship in Addiction Medicine is to train physician addiction medicine leaders in clinical care, research, education, public health, and advocacy to improve addiction care for people vulnerable to health inequities due to race, ethnicity, gender, poverty, age, disability or stigmatizing illness.

The Grayken Addiction Medicine Fellowship Program is a 1 or 2 year fellowship. There is also a 3-year combined Infectious Disease-Addiction Medicine Fellowship and a 2-year Fellowship in Maternal Health Addiction. Fellows are mentored by our multidisciplinary faculty from Internal Medicine, Infectious Disease, Emergency Medicine, Obstetrics & Gynecology and Addiction Psychiatry. The Grayken Fellowship in Addiction Medicine is accredited by the ACGME. Click here to learn more